Sensydia
Anthony has over 25 years experience in the development of successful, high-tech medical devices. Anthony was the CEO and a board member for SetPoint Medical where he grew the company from a three-person start-up to the leading clinical-stage bioelectronic medicine company. Prior to SetPoint he served as VP of Marketing for Boston Scientific and was Director of Marketing at Medtronic. Anthony serves as advisor and board member for numerous early-stage device companies.
Sensydia
1 followers
Sensydia is developing a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases.